Form 4: Perspective Therapeutics Director Lori Woods Reports Stock Transactions
SEC Form 4 Filing
Director Lori Woods reports acquiring and disposing of Perspective Therapeutics (CATX) common stock through direct and indirect ownership.
Summary
- On June 14, 2024, Lori Woods, a director of Perspective Therapeutics, Inc. (CATX), reported transactions involving the company's common stock.
- Woods acquired 4,504 shares at $10.9 each and 83 shares at $10.8 each through the Woods Family Living Trust.
- Woods also disposed of 4,807 shares of common stock.
- Following these transactions, Woods beneficially owns 159,985 shares indirectly through the Woods Family Living Trust.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for directors and officers of publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how they interpret the director's trading activity.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of stock transactions (acquisition and disposition). |
| 06/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.